Local Organizing Committee’s next two on the list of 10 “must visit” places in Seoul. Thanks to the Cytokines 2024 LOC member Jae Hun Shin, PhD, Yonsei University, Korea, we will feature two of the top 10 things to do in Seoul. If you missed the first two please click here. [READ MORE]
I am a fan of musical theatre, and scientific meetings definitely have some aspect of performance – just imagine if speakers had to sing their talks? Perhaps a musical about cytokines could be the next hot thing to come to Broadway or the West End? Here are some proposed titles: [READ MORE]
Signals+ Editorial Board member, Maialen Sebastian, recently caught up with a 2023 ICIS-Pfizer Junior Investigator Award recipient, Iolanda Miceli for this interview. “I am concurrently completing my medical degree and scientific training at Monash University Melbourne. I never anticipated that my medical degree would morph into a PhD program as [READ MORE]
Brian G. Morreale, M.Sc. (They/Them) Pre-Doctoral Candidate, Laboratory of Scott Abrams, PhD., Dept. of Immunology Roswell Park Comprehensive Cancer Center, Buffalo, USA @MorrealeBrian After graduating Daemen College in Amherst, NY, Mr. Morreale received his master’s degree in Cancer Sciences at Roswell Park Comprehensive Cancer Center, Buffalo, NY. There he was [READ MORE]
Congratulations to the following Lifetime ICIS members have been elected into the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.
Kaech, Susan M.; professor and director, NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, Calif.
O’Garra, Anne; professor and principal group leader, Immunoregulation and Infection Laboratory, The Francis Crick Institute (United Kingdom)
Trinchieri, Giorgio; chief, Laboratory of Integrative Cancer Immunology, distinguished investigator, and head, Cancer Immunology Section, Center for Cancer Research, National Institutes of Health, Bethesda, Md.
As well as long time ICIS member Mantovani, Alberto; emeritus professor of general pathology and vice rector for research, Humanitas University (Italy) [READ MORE]
Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory CancersClinicalTrials.gov ID NCT03388632Sponsor National Cancer Institute (NCI)Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party) Interleukin-34 Level in Periodontal DiseaseClinicalTrials.gov ID NCT05962567Sponsor Ain Shams UniversityInformation provided by Nada Zidan, Ain Shams University (Responsible Party) TNFalpha and Interleukin 2 [READ MORE]
Students and Postdoctoral Researchers presenting novel and promising research may apply to receive a travel award to partially cover travel expenses. [READ MORE]
Have You Started Making Your Plan to Attend Cytokines 2024 / KAI 2024? Here’s Two More “Must Visit” Places in Seoul – and the latest list of symposia speakers confirmed by the Cytokine 2024 secretariat. [READ MORE]
Prof. Michael Gale, Jr. to head University of Minnesota’s Department of Microbiology and Immunology and become Director of the Institute on Infectious Diseases [READ MORE]
EDWARD CHUONG, Assistant Professor at the BioFrontiers Institute, at the University of Colorado Boulder My lab studies the interplay between transposons and immune evolution. We can think of transposons as a genetic infection that we can never get rid of. Although our cells have evolved defenses against them, transposons are [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
